Novartis Investigative Site
Hilversum XZ1213
0 studies enrolling now · 2 studies all time
What they study most
Breast Cancer, Neoplasms, Breast
Studies at this site
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
— Completed
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC
— Completed